US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision loss
· euronews.com · popularity 20/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at euronews.com →
Summary
The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
Found in: Euronews. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.